COSCIENS Biopharma Inc T.AEZS

Oat beta glucan pill and wound healing?

[prophetoffactz]

Ceapro's oat beta glucan could potentially be used for wound healing, in addition to its cholesterol-lowering effects, based on the following evidence:

• Studies have shown that oat beta glucan is highly effective in stimulating collagen synthesis and can play a prominent role in skin restructuring and wound healing.
• In a recent animal study, 1% oat beta glucan treatment resulted in earlier wound closure in mice compared to controls. The BG-treated tissue exhibited more microvessels (angiogenesis) and the presence of endothelial progenitor cells. BG treatment also resulted in increased collagen fiber width and length, more resembling normal tissue architecture compared to scar tissue.
• The researchers concluded that oat-based bioactives like beta glucan exhibited potential to improve regenerative wound healing, reduce inflammation, promote angiogenesis, and reduce scar formation.
• Ceapro is developing oat beta glucan beyond the personal care market into the nutraceutical and/or pharmaceutical space to target metabolic diseases. A cholesterol-lowering clinical trial is currently underway.

So while the current clinical trial is focused on cholesterol reduction, Ceapro's oat beta glucan could potentially be repurposed or further studied for its wound healing properties, given the promising preclinical data. However, additional clinical research would be needed to demonstrate its efficacy for wound healing in humans.